Showing results (91-100 of 5,594) with videos related to
Sort By:
Pageof 560
ACS Medicinal Chemistry Letters|August 20, 2025
Novel Isoindolinone-Containing PARP Inhibitors: Synthesis and Therapeutic Applications in CNS Cancer TreatmentXin Zhou, Steven H LiangViruses|April 27, 2026
The Key Role of Complement Receptor CRIg in Kupffer Cell-Mediated Liver Disease ProgressionXin-Zhou Sun, Yan LiuLeukemia & Lymphoma|September 6, 2023
Baseline correlates of frailty and its association with survival in United States veterans with acute myeloid leukemiaJennifer La, Michelle H Lee, Mary T Brophy, et al.Drug Design, Development and Therapy|July 16, 2021
An Update Review of Biosimilars of Adalimumab in Psoriasis - Bioequivalence and InterchangeabilityXin Zhou, Zhuo Chen, Xinling BiPharmacology Research & Perspectives|June 15, 2021
Daratumumab provides a survival benefit in relapsed and refractory Multiple Myeloma, independent of baseline clinical characteristics: A meta-analysisCongcong Cao, Xin Zhou, Qun MaInjury|June 11, 2022
Coverage of exposed ankle and foot with the conjoined lower abdomen and groin flapsLin Tang, Xin Zhou, Yonggen ZouBioresource Technology|March 19, 2019
Electrodialytic bioproduction of xylonic acid in a bioreactor of supplied-oxygen intensification by using immobilized whole-cell Gluconobacter oxydans as biocatalystXin Zhou, Jian Han, Yong XuBiochemical and Biophysical Research Communications|July 23, 2013
MicroRNA-340 suppresses osteosarcoma tumor growth and metastasis by directly targeting ROCK1Xin Zhou, Min Wei, Wei WangMikrochimica Acta|November 11, 2018
Colorimetric human papillomavirus DNA assay based on the retardation of avidin-induced aggregation of gold nanoparticlesJingyu Piao, Xin Zhou, Xue WuOncotargets and Therapy|June 18, 2015
Clinical utility and patient consideration in the use of lenalidomide for multiple myeloma in Chinese patientsJing Wang, Hongfeng Guo, Xin ZhouPageof 560